The Novo Nordisk Pro Cycling Team share how they manage their T1D while competing across the globe. Click the image to read their stories.
The OmniPod DASH insulin management system from Insulet, recently cleared by the FDA for patient use. Click the image for more details.
Get the latest information on up-to-date insulin pump technology, like the new Basal IQ Pump, from Tandem Diabetes Care. Click the image for more information.
The Eversense CGM System is for people who want to actively manage their diabetes simply and confidently. (Click the photo for more information)
The FreeStyle Libre 14 day sensor automatically measures glucose readings day and night and is accurate for insulin dosing. (Click the photo for more information)
The InPen insulin injector pen. An easy-to-use pen that not only helps calculate your doses but also keeps track of injection data. (Click the photo for more information)
Trying to keep your blood sugar in range can be stressful and time consuming. Our Control-IQ advanced hybrid closed-loop technology makes it easier by predicting and helping to prevent highs and lows. (click to read more)

Vanderbilt Diabetes Technology Program

Happening Now and Next

A look at what's new in the world of diabetes research and technology

"Open source (a.k.a. DIY) automated insulin delivery: addressing the challenge"

Do-it-yourself automated insulin delivery systems for people living with type 1 diabetes use commercially available continuous glucose sensors and insulin pumps linked by unregulated open source software. Uptake of these systems is increasing, with growing evidence suggesting that positive glucose outcomes may be feasible. Increasing interest from people living with, or affected by, type 1 diabetes presents challenges to healthcare professionals, device manufacturers and regulators as the legal, governance and risk frameworks for such devices are not defined. We discuss the data, education, policy, technology and medicolegal obstacles to wider implementation of DIY systems and outline the next steps required for a co-ordinated approach to reducing variation in access to a technology that has potential to enable glucose self-management closer to target.

Read more here>>